Geri
NewcelX AG (NCEL) Fiyatı
NCEL Hisse Senedi Fiyat Grafiği
NCEL Kazanmak
NewcelX AG
$2.77
4.92%
$0.12
Kapanışta: Feb 06, 16:00:00 GMT-5
$2.77
0%
$0
Sonrası Piyasa: Feb 06, 20:00:00 GMT-5
Earnings FAQ
NCEL'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
NewcelX AG NCEL'ün son çeyrekteki geliri nasıl performans gösterdi?
NewcelX AG'in gelir tahmini nedir?
NewcelX AG'in kazanç kalite puanı nedir?
NewcelX AG kazançlarını ne zaman rapor eder?
NewcelX AG'in beklenen kazançları nelerdir?
NewcelX AG kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$2.64
Açılış fiyatı
$2.7
Günün Aralığı
$2.64 - $2.84
52 haftalık aralık
$1.89 - $30.8
İşlem hacmi
8.4K
Ort.Hacim
121.0K
EPS (TTM)
-5.27
Dividend yield
--
Piyasa Değeri
$12.6M
NCEL nedir?
NewcelX AG is a CH-based company operating in Biotechnology industry. The company is headquartered in Zurich, Zuerich and currently employs 1 full-time employees. The company went IPO on 2021-01-29. NewcelX AG, formerly NLS Pharmaceutics AG, is a Switzerland-based company primarily engaged in the biotechnology industry. The firm focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The firm offers products like Quilience, which is a clinical-stage pharmaceutical compound. The company aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The firm also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The firm is a publicly traded company, listing on the NASDAQ.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved